NCT03088540 2026-02-23Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)Regeneron PharmaceuticalsPhase 3 Completed712 enrolled 1 FDA